Board Meeting Intimation for Approval And Take On Record Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026 (H1) Of Financial Year 2026-27 And Consider Declaration Of An Interim Dividend To The Equity Shareholders.
Filed with BSE · · 1 page · English
Summary by 6ix AI
Amwill Health Care Ltd has announced a board meeting to discuss financial results and an interim dividend. The meeting is scheduled for a date in late October to review unaudited financial results for the first half of the financial year. The company has also noted that the trading window for its securities is currently closed due to insider trading regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Amwill Health Care
- Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Grant Of Licence/Regulatory Approval For Import Of Folicolor- Oxidative Hair Colour.
- Amwill Health Care Ltd Press Release Sep 28 2026
- Amwill Health Care Ltd Press Release Sep 25 2026
- Amwill Health Care Ltd Press Release Aug 14 2026
- Amwill Health Care Ltd Press Release Aug 08 2026
Later from Amwill Health Care
- Board Meeting Outcome for Board Meeting Outcome Of The Meeting Of The Board Of Directors Held On October 23Rd, 2026.
- Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026, For The Financial Year 2026-27.
- Disclosure Under Regulation 42 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
- Corporate Action-Board approves Dividend
Follow Amwill Health Care into a list and get an email when it puts out news.
Follow Amwill Health Care